Clinical Trial Update: Comparison of Ticagrelor vs. Prasugrel on Inflammation, Arterial Stiffness, Endothelial Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Coronary Stenting [Phase 4]

View source ↗

Summary

Phase 4 trial comparing ticagrelor and prasugrel on inflammation, arterial stiffness, endothelial function, and circulating endothelial progenitor cells in diab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Non-st-elevation Acute Coronary Syndrome

Drugs mentioned

• PRASUGREL (prasugrel)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Korea University Anam Hospital | Conditions: Acute Coronary Syndrome | Phase 4 | Status: COMPLETED